Teresa Sardon / System biology approaches to personalized medicine

1,521 views

Published on

Presentation given by Teresa Sardon from Anaxomics Biotech SL in the framework of the Emergence Forum Barcelona

Biocat organized the Barcelona Emergence Forum (April 10-11th, 2014, Congress Palace, Montjuïc) supported by the TRANSBIO SUDOE, a translational cooperation project dedicated to innovation in life sciences in South-West Europe. The Barcelona Emergence Forum contributed to bringing together Academics, Companies, Investment Entities, Technology Platforms and Technology Transfer Offices from Spain, France and Portugal to set up collaborative projects on Human Health & Agro-food Innovation.
More information at: http://www.b2match.eu/emergenceforum2014

Published in: Healthcare, Technology, Business
0 Comments
1 Like
Statistics
Notes
  • Be the first to comment

No Downloads
Views
Total views
1,521
On SlideShare
0
From Embeds
0
Number of Embeds
11
Actions
Shares
0
Downloads
36
Comments
0
Likes
1
Embeds 0
No embeds

No notes for slide

Teresa Sardon / System biology approaches to personalized medicine

  1. 1. System Biology Approaches to Personalized Medicine © Anaxomics 2014 Teresa Sardon MSc, PhD Head of BU - Analytical Services
  2. 2. Member of eight EU 7th Framework Programme research consortia Finalist in 2011 Red Herring Top 100 Europe 4th place in IMPROVER Challenge 2012 Founded in 2007 – Private capital Based in Barcelona 20 Experts (Pharmacology, Physiology, Artificial Intelligence) Proprietary technology: Therapeutic Performance Mapping System (TPMS) Company Profile Academic Researchers Pharmaceutical companies Nutraceuticals Clinical Researchers CROs Cosmetics Biotechnology companies Venture Capital Veterinary Industry © Anaxomics 2014 OUR CLIENTS: ACHIEVEMENTS: OUR GOAL: “Applying Systems Biology to Health & Life Science to provide solutions to the most challenging biological and medical needs“
  3. 3. Systems Biology + data from different sources → Mathematical Models Systems Biology © Anaxomics 2014 Efficacy and safety assessment Molecular and clinical model Mechanism of action Target discovery Combination therapies Drug repositioning – New indications Biomarkers discovery
  4. 4. © Anaxomics 2014 Shared characteristics Clinical data Omics • Genomics • Proteomics • Transcriptomics • Metabolomics … + Experimental data From Systems Biology to Personalized Medicine Cohort 1 Cohort 2
  5. 5. Responders Non-responders © Anaxomics 2014 MoA Biomarkers Treatment Selection Case Study: Treatment Responders and Non Responders MoA Reversion
  6. 6. How do you get it? © Anaxomics 2014 Consulting Services: Fee for Service Partnership Agreements: -Service Platforms -Research Instituts -Other companies CONTACT US: teresa.sardon@anaxomics.com info@anaxomics.com Thanks for your attention!

×